QuidelOrtho enters retirement program with SVP R&D Kroll, extends special advisor agreement with Steward

QuidelOrtho Corp

Werner Kroll (SVP R&D) receives $1M/year equity grants (options/RSUs) for 2023, 2024, 2025 with performance- and time-based vesting.
Kroll's employment extended through March 2025; thereafter one-year non-officer special advisor role at reduced pay.
Randall Steward continues as non-officer special advisor at $300,000/year through March 2024; outstanding equity awards continue to vest.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.